Product
YPEG-rhEPO
1 clinical trial
1 indication
Indication
Anemia of Chronic Kidney DiseaseClinical trial
A Multicenter, Randomized, Open-label, Phase 2 Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease, Who Has Previously Treated With rhEPO and Maintains the Hemoglobin in a Stabilize StateStatus: Completed, Estimated PCD: 2022-01-05